Birkett Bernard
- SEC CIK
- 0001658001
No open-market purchases or sales filed in the past year.
Current role at each company
- WST West Pharmaceutical Services IncSr VP, Chief Financial Officeras of Feb 20, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Birkett Bernard as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 8, 2023 (view filing) | Aug 2 | 6 daysLate | Birkett BernardSr VP, Chief Fin & Ops Off | SSale | −22.3K | $370.39 | −$8.27M | −83.6%4.37K after | 2 lots |
| Aug 3, 2022 (view filing) | Aug 2 | 1 day | Birkett BernardSr VP, CFO & COO | SSale | −14.2K | $341.20 | −$4.84M | −94.7%795 after | 4 lots |